Does Aspirin Cause Erectile Dysfunction?

Most people taking aspirin do not experience erectile dysfunction (ED), and current evidence is mixed rather than definitive. Several human studies suggest no clear increase in ED risk with aspirin, and some small trials even report improved erections in men with vascular (blood‑flow) ED. [PM21] [PM10] At the same time, a recent genetic study in Europeans raised a possible association, but this approach has limitations and does not prove day‑to‑day clinical causation. [PM7] Overall, aspirin is not widely recognized as a direct ED‑causing drug, and if ED occurs, other medical causes are often more likely.

What the Evidence Shows

• No clear link in large observational data: A well‑designed analysis from the Prostate Cancer Prevention Trial found that non‑steroidal anti‑inflammatory drugs (NSAIDs), including aspirin, were not associated with higher ED risk when medical reasons for taking NSAIDs were considered. [PM21]

• Potential benefit in vasculogenic ED: A meta‑analysis of randomized trials (2 small RCTs, 214 men) found aspirin improved erectile function scores compared with placebo in men with blood‑vessel–related ED, although the evidence base is limited and dosing varied. [PM10] A randomized study also reported aspirin efficacy in men with vasculogenic ED and high mean platelet volume. [PM18] Another comparative trial suggested tadalafil plus aspirin could outperform either drug alone in vascular ED, though bleeding risk needs careful assessment. [PM20]

• Basic science and literature reviews: Animal data showed long‑term aspirin did not worsen erectile function in adult or aging rats, supporting a neutral effect on penile nitric oxide pathways under study conditions. [PM9] A broader review of antithrombotic drugs concluded aspirin’s relationship with ED is inconsistent across reports, with signals ranging from possible benefit to moderate risk, and overall less risk than certain other antiplatelets (like clopidogrel). [PM11]

• Genetic (Mendelian randomization) signal: A 2023 MR study suggested a potential causal association between aspirin use and ED in European populations, but MR infers causality indirectly and can be affected by instrument choice and confounders; findings need confirmation in clinical trials. [PM7]

Possible Mechanisms (Why ED Could Seem Related)

• Vascular and platelet effects: Aspirin inhibits platelet cyclooxygenase, reducing thromboxane A2, a mediator of platelet aggregation and vasoconstriction; in theory, this could help microvascular blood flow, which aligns with some positive ED trial signals. ^{[1] [2]} Conversely, real‑world ED is multifactorial, and coexisting cardiovascular disease, diabetes, high blood pressure, and smoking are far more common drivers. When ED appears while on aspirin, underlying heart or metabolic conditions are frequent culprits rather than aspirin itself. ^{[3] [4] [5]}

• Medication interactions and bleeding risk: ED treatments like PDE5 inhibitors (sildenafil, tadalafil) are generally safe in heart disease but must not be combined with nitrates; aspirin does not directly block PDE5 inhibitor use, though bleeding disorders require caution. ^[6] If bruising, nosebleeds, or gastrointestinal bleeding occur, ED use of other therapies should be reviewed carefully. ^{[7] [8]}

Who Might Be More at Risk?

• Men with multiple cardiovascular risk factors: ED often precedes or accompanies cardiovascular disease via endothelial dysfunction; aspirin is frequently taken because of vascular risk, which can confound the perceived link. In such cases, ED likely reflects vascular health rather than an aspirin side effect. ^{[3] [4] [5]}

• Men on other antithrombotics: Some antiplatelets have stronger associations with sexual side effects than aspirin; switching agents is sometimes considered if sexual dysfunction emerges, though decisions must be individualized. [PM11]

Practical Ways to Cope

Step 1: Review basics

• Assess timing: If ED started after aspirin initiation and no other changes occurred, note the dose and onset, but keep in mind that coincidence with evolving vascular risk is common. A medication timeline helps your clinician separate drug effects from underlying disease. [PM21]

• Check cardiovascular and metabolic health: Screen blood pressure, lipids, blood sugar, weight, sleep apnea, smoking, and exercise habits. Optimizing heart and metabolic health often improves erections. ^{[3] [4] [5]}

Step 2: Optimize lifestyle

• Heart‑healthy habits: Regular aerobic exercise, weight management, smoking cessation, and a Mediterranean‑style diet support endothelial function and penile blood flow. These measures reduce ED driven by vascular causes regardless of aspirin use. ^{[3] [4]}

Step 3: Consider ED‑specific therapy

• PDE5 inhibitors first‑line: Sildenafil or tadalafil are effective and generally safe with aspirin; avoid only if you use nitrates or have specific contraindications. They may even offer cardiovascular benefits under expert guidance. ^[6]

• Aspirin trial modification: If ED clearly coincides with aspirin and other causes have been addressed, discuss with your clinician whether dose adjustment or a temporary pause is appropriate based on your cardiovascular indication; never stop aspirin without medical advice. Risk–benefit must consider why aspirin was prescribed (e.g., secondary prevention after heart attack or stroke). ^{[3] [4] [5]}

• Combination approaches in vascular ED: In selected cases, clinicians may combine antiplatelet strategies with ED medications, weighing bleeding risk and individual factors. Such plans should be supervised to ensure safety. [PM18] [PM20]

Step 4: Address other contributors

• Medications: Some drugs (certain antidepressants, antihypertensives) can affect erections; a careful review can uncover modifiable culprits. Aspirin is rarely the sole driver compared with these classes. [PM11]

• Psychological factors: Stress, anxiety, and relationship issues can amplify ED; counseling or sex therapy can be highly effective alongside medical care. Mind‑body approaches complement medical treatment and improve outcomes. ^[3]

When to Seek Medical Advice

• Red flags: New ED with chest pain, shortness of breath, or exercise intolerance warrants urgent cardiovascular evaluation since ED can be an early sign of heart disease. Prompt assessment protects both sexual and heart health. ^{[3] [4] [5]}

• Bleeding symptoms on aspirin: Black stools, vomiting blood, easy bruising, or nosebleeds should be evaluated promptly; ED therapies may need adjustment if bleeding risk is high. Safety takes priority before changing ED medications. ^{[1] [9]}

Bottom Line

• Aspirin does not consistently cause ED, and many men tolerate it without sexual side effects. [PM21] Evidence even suggests possible benefit in men with vasculogenic ED, though data are limited and further trials are needed. [PM10] If ED occurs while on aspirin, focus first on cardiovascular and metabolic health, review other medications, and consider established ED treatments, while discussing any aspirin changes only with your clinician based on your specific heart and stroke prevention needs. ^{[6] [3] [4] [5]}

---